Related references
Note: Only part of the references are listed.
Article
Pharmacology & Pharmacy
Clemence Lacroix et al.
Summary: This report highlights the importance of pharmacovigilance monitoring and surveillance in France during the COVID-19 vaccination campaign, emphasizing the need to ensure the safety of vaccine administration.
Article
Pharmacology & Pharmacy
Antoine Pariente et al.
Summary: The marketing authorization granted to SARS-Cov-2 vaccines was accompanied by reinforced safety monitoring plans, which were implemented in Europe through a combination of pharmacovigilance and pharmacoepidemiology activities. While pharmacovigilance is better at detecting safety signals for rare events, pharmacoepidemiology complements it by monitoring more common events.
Article
Pharmacology & Pharmacy
Dominique Deplanque et al.
Summary: The COVID-19 pandemic caused by SARS-CoV-2 has led to rapid vaccine development, with most vaccines proving to be safe and effective in clinical trials. These vaccines have shown overall efficacy in reducing the severity of the disease and potentially impacting mortality rates, which could change the course of the pandemic.
Article
Pharmacology & Pharmacy
Jean-Louis Montastruc et al.
Summary: Social pharmacology explores the relationships between society and drugs, focusing on factors, reasons, consequences, and representations of drug use in society. The recent development and marketing of COVID-19 vaccines have raised questions about how vaccines are perceived at individual, population, and societal levels, as well as the acceptability of vaccines during a pandemic. Various proposals are being made to address these social pharmacology issues at both individual and collective levels.
